PT Prodia Diagnostic Line Tbk (IDX:PRDL)

Revenue by Segment

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Clinical Chemistry	60.38B	50.59B	93.99B
Hematology	4.09B	1.06B	93.03M
Instrument	8.83B	6.89B	16.53B
Immunology & Biomoleculer	56.57M	25.59M	962.88M
Services	1.02B	83.30M	202.00M
Total	74.37B	58.66B	111.78B

Revenue by Geography

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Indonesia	74.37B	58.66B	111.78B
Total	74.37B	58.66B	111.78B

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error